These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21273662)
1. Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus. Domin H; Zięba B; Gołembiowska K; Kowalska M; Dziubina A; Śmiałowska M Pharmacol Rep; 2010; 62(6):1051-61. PubMed ID: 21273662 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures. Domin H; Kajta M; Smiałowska M Pharmacol Rep; 2006; 58(6):846-58. PubMed ID: 17220542 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Lea PM; Movsesyan VA; Faden AI Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750 [TBL] [Abstract][Full Text] [Related]
4. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo. Domin H; Gołembiowska K; Jantas D; Kamińska K; Zięba B; Smiałowska M Neurotox Res; 2014 Jul; 26(1):99-113. PubMed ID: 24402869 [TBL] [Abstract][Full Text] [Related]
5. Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus. Śmiałowska M; Gołembiowska K; Kajta M; Zięba B; Dziubina A; Domin H Neurotox Res; 2012 May; 21(4):379-92. PubMed ID: 22144346 [TBL] [Abstract][Full Text] [Related]
6. MTEP, a Selective mGluR5 Antagonist, Had a Neuroprotective Effect but Did Not Prevent the Development of Spontaneous Recurrent Seizures and Behavioral Comorbidities in the Rat Lithium-Pilocarpine Model of Epilepsy. Dyomina AV; Kovalenko AA; Zakharova MV; Postnikova TY; Griflyuk AV; Smolensky IV; Antonova IV; Zaitsev AV Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008924 [TBL] [Abstract][Full Text] [Related]
7. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526 [TBL] [Abstract][Full Text] [Related]
8. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Hao Y; Martin-Fardon R; Weiss F Biol Psychiatry; 2010 Aug; 68(3):240-8. PubMed ID: 20416862 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP. Gass JT; Olive MF Eur J Pharmacol; 2008 Apr; 584(2-3):253-62. PubMed ID: 18346726 [TBL] [Abstract][Full Text] [Related]
10. Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats. Gravius A; Dekundy A; Nagel J; Morè L; Pietraszek M; Danysz W J Neural Transm (Vienna); 2008 Dec; 115(12):1609-19. PubMed ID: 18690408 [TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. Bradbury MJ; Campbell U; Giracello D; Chapman D; King C; Tehrani L; Cosford ND; Anderson J; Varney MA; Strack AM J Pharmacol Exp Ther; 2005 Apr; 313(1):395-402. PubMed ID: 15590770 [TBL] [Abstract][Full Text] [Related]
12. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats. Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858 [TBL] [Abstract][Full Text] [Related]
13. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo. Szydlowska K; Kaminska B; Baude A; Parsons CG; Danysz W Eur J Pharmacol; 2007 Jan; 554(1):18-29. PubMed ID: 17109843 [TBL] [Abstract][Full Text] [Related]
15. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. Cowen MS; Djouma E; Lawrence AJ J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750 [TBL] [Abstract][Full Text] [Related]
16. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum. Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139 [TBL] [Abstract][Full Text] [Related]
17. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties. Swedberg MD; Ellgren M; Raboisson P J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity. Popoli P; Pintor A; Tebano MT; Frank C; Pepponi R; Nazzicone V; Grieco R; Pèzzola A; Reggio R; Minghetti L; De Berardinis MA; Martire A; Potenza RL; Domenici MR; Massotti M J Neurochem; 2004 Jun; 89(6):1479-89. PubMed ID: 15189351 [TBL] [Abstract][Full Text] [Related]
19. Astaxanthin protects against kainic acid-induced seizures and pathological consequences. Chang Y; Lu CW; Chen YJ; Lin TY; Huang SK; Wang SJ Neurochem Int; 2018 Jun; 116():85-94. PubMed ID: 29475038 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death. Domin H; Jantas D; Śmiałowska M Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]